Nav: Home

Houston Methodist receives $9 million from NCI to study physics of cancer immunotherapy

October 04, 2016

HOUSTON-(Oct. 3, 2016)-The Houston Methodist Research Institute has been awarded a $9 million grant from the National Cancer Institute to establish a research center focused on the physics of cancer immunotherapy.

The Houston Methodist Research Institute will be the lead site for the NCI-designated Center for Immunotherapeutic Transport Oncophysics (CITO), which focuses on designing immunotherapies for breast and pancreatic cancers. While several immunotherapies have been approved by the U.S. Food and Drug Administration, the use of immunotherapy to treat these intractable cancers has been less effective.

Houston Methodist is partnering with the University of Texas M.D. Anderson Cancer Center and UT Southwestern to receive the NCI grant to explore physiological changes during cancer progression. Studying the body's changes, rather than simply focusing on the tumor, will help researchers create more effective and personalized treatments with fewer side effects.

Through a multidisciplinary and multi-institutional research team led by Mauro Ferrari, Ph.D., president and CEO of the Houston Methodist Research Institute, the CITO will combine the studies of cancer immunology, biotechnology and transport oncophysics (mass transport within cancer cells) to reveal how immunotherapy works in cancer patients.

Ferrari, considered a pioneer of transport oncophysics explained, "Many cancer patients do not respond to immunotherapies, typically because the drugs never reach the cancer cells. While transport oncophysics is a relatively young field of study, we need to understand the limitations of treatments to identify effective immunotherapies for patients."

The center's goal is to use research information to personalize immunotherapies for the treatment of breast and pancreatic cancers: topics of the two major center projects.

The first project will determine how nano-dendritic cell vaccines, containing immune cells loaded with nanoparticles, are transported to breast cancers. The second project aims to identify the transport barriers keeping immunotherapies from reaching pancreatic tumors.

Houston Methodist is one of 10 institutions receiving an NCI center grant. Others include Cornell University, Dana-Faber Cancer Institute, Johns Hopkins University and Massachusetts Institute of Technology (MIT).
-end-
To speak with Mauro Ferrari, Ph.D., contact Patricia Akinfenwa, Houston Methodist, at 281.740.1402 or pakinfenwa@houstonmethodist.org. For more information about Houston Methodist, visit houstonmethodist.org. Follow us on Twitter and Facebook.

Houston Methodist

Related Cancer Cells Articles:

Scientists have identified the presence of cancer-suppressing cells in pancreatic cancer
Researchers have identified cells containing a protein called Meflin that has a role in restraining the progression of pancreatic cancer.
Changes in the metabolism of normal cells promotes the metastasis of ovarian cancer cells
A systematic examination of the tumor and the tissue surrounding it -- particularly normal cells in that tissue, called fibroblasts -- has revealed a new treatment target that could potentially prevent the rapid dissemination and poor prognosis associated with high-grade serous carcinoma (HGSC), a tumor type that primarily originates in the fallopian tubes or ovaries and spreads throughout the abdominal cavity.
The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.
White blood cells related to allergies may also be harnessed to destroy cancer cells
A new Tel Aviv University study finds that white blood cells which are responsible for chronic asthma and modern allergies may be used to eliminate malignant colon cancer cells.
Conversion of breast cancer cells into fat cells impedes the formation of metastases
An innovative combination therapy can force malignant breast cancer cells to turn into fat cells.
More Cancer Cells News and Cancer Cells Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...